Repare announces strategic reprioritization, to lay off 25% of workforce
PremiumThe FlyRepare announces strategic reprioritization, to lay off 25% of workforce
2M ago
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
Premium
The Fly
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
3M ago
Repare Therapeutics Advances Oncology Trials and Preps for 2025
Premium
Company Announcements
Repare Therapeutics Advances Oncology Trials and Preps for 2025
3M ago
Repare Therapeutics announces intial data from Phase 1 MINOTAUR trial
PremiumThe FlyRepare Therapeutics announces intial data from Phase 1 MINOTAUR trial
4M ago
Repare Therapeutics doses first patient in camonsertib trial
Premium
The Fly
Repare Therapeutics doses first patient in camonsertib trial
5M ago
Repare announces FDA fast track designation for Lunresertib-Camonsertib combo
Premium
The Fly
Repare announces FDA fast track designation for Lunresertib-Camonsertib combo
5M ago
Repare Therapeutics reinstated with a Buy from Accumulate at Bloom Burton
PremiumThe FlyRepare Therapeutics reinstated with a Buy from Accumulate at Bloom Burton
7M ago
SHAREHOLDER ALERT: Potential Recovery for Repare Therapeutics Inc. (RPTX) Investors
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for Repare Therapeutics Inc. (RPTX) Investors
8M ago
Repare Therapeutics Reports Promising 2023 Progress
Premium
Company Announcements
Repare Therapeutics Reports Promising 2023 Progress
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100